Usefulness of daily folic acid supplementation during methotrexate treatment of Japanese patients with rheumatoid arthritis
Authors:
- 30 March 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 31 (1) , 108-113
Abstract
Objectives: We investigated the effect of daily folic acid supplementation on methotrexate (MTX) toxicity and efficacy in Japanese patients with rheumatoid arthritis (RA). Methods: We followed 19 patients treated with MTX who switched from taking weekly 5 mg folic acid supplementation (weekly regimen) to 1.25 mg daily (daily regimen). White blood cell (WBC) and platelet (PLT) counts, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels were collected for 24 weeks following the change. Results: We observed no significant changes in WBC or PLT counts. AST and ALT levels, which had exceeded the upper limits of their normal ranges at the beginning of the study, were improved significantly at weeks 4 and 8, no subsequent deterioration in liver function was found. Further, no significant changes in ESR and CRP levels were observed. Conclusion: Our data indicate that supplementing 1.25 mg of folic acid daily rather than 5 mg weekly reduces toxicity caused by MTX without affecting its efficacy.Keywords
Funding Information
- Scientific Research
- Ministry of Education, Science, Culture, Sports and Technology of Japan (17K08447)
This publication has 18 references indexed in Scilit:
- Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in JapanEuropean Journal Of Cancer Prevention, 2009
- Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)Annals of the Rheumatic Diseases, 2007
- Reduction of the efficacy of methotrexate by the use of folic acid: Post hoc analysis from two randomized controlled studiesArthritis & Rheumatism, 2005
- Declines in Mortality From Acute Myocardial Infarction in Successive Incidence and Birth Cohorts of Patients With Rheumatoid ArthritisCirculation, 2004
- Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate: Risk factors and response to folic acidScandinavian Journal of Rheumatology, 1999
- Methotrexate in rheumatoid arthritis. a five‐year prospective multicenter studyArthritis & Rheumatism, 1994
- Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritisRheumatology International, 1994
- The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritisArthritis & Rheumatism, 1990
- Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapyCancer, 1973
- Long-Term Remissions in Childhood Acute LeukemiaClinical Pediatrics, 1966